Your browser doesn't support javascript.
loading
Advanced glycation end-products are a risk for muscle weakness in Japanese patients with type 1 diabetes.
Mori, Hiroyasu; Kuroda, Akio; Araki, Michiko; Suzuki, Reiko; Taniguchi, Satoshi; Tamaki, Motoyuki; Akehi, Yuko; Matsuhisa, Munehide.
Affiliation
  • Mori H; Diabetes Therapeutics and Research Center, Institute of Advanced Medical Sciences, Tokushima University, Tokushima, Japan.
  • Kuroda A; Diabetes Therapeutics and Research Center, Institute of Advanced Medical Sciences, Tokushima University, Tokushima, Japan.
  • Araki M; Department of Nutrition and Metabolism, Institute of Biomedical sciences, Tokushima University Graduate School, Tokushima, Japan.
  • Suzuki R; Diabetes Therapeutics and Research Center, Institute of Advanced Medical Sciences, Tokushima University, Tokushima, Japan.
  • Taniguchi S; Diabetes Therapeutics and Research Center, Institute of Advanced Medical Sciences, Tokushima University, Tokushima, Japan.
  • Tamaki M; Diabetes Therapeutics and Research Center, Institute of Advanced Medical Sciences, Tokushima University, Tokushima, Japan.
  • Akehi Y; Diabetes Therapeutics and Research Center, Institute of Advanced Medical Sciences, Tokushima University, Tokushima, Japan.
  • Matsuhisa M; Diabetes Therapeutics and Research Center, Institute of Advanced Medical Sciences, Tokushima University, Tokushima, Japan.
J Diabetes Investig ; 8(3): 377-382, 2017 May.
Article in En | MEDLINE | ID: mdl-27727515

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Glycation End Products, Advanced / Muscle Weakness / Diabetes Mellitus, Type 1 / Sarcopenia Type of study: Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: J Diabetes Investig Year: 2017 Document type: Article Affiliation country: Japan Country of publication: Japan

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Glycation End Products, Advanced / Muscle Weakness / Diabetes Mellitus, Type 1 / Sarcopenia Type of study: Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: J Diabetes Investig Year: 2017 Document type: Article Affiliation country: Japan Country of publication: Japan